enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Pembrolizumab - Wikipedia

   en.wikipedia.org/wiki/Pembrolizumab

   People have had severe infusion-related reactions to pembrolizumab. There have also been severe immune-related adverse effects including lung inflammation (including fatal cases) and inflammation of endocrine organs that caused inflammation of the pituitary gland, of the thyroid (causing both hypothyroidism and hyperthyroidism in different people), and pancreatitis that caused Type 1 diabetes ...

3. Merck's Keytruda sets new 5-year survival standard for ... - AOL

   www.aol.com/news/mercks-keytruda-sets-5-survival...

   Nearly a quarter of patients who received Merck & Co's immunotherapy Keytruda as an initial treatment for advanced lung cancer were still alive after five years, according to data presented at a ...

4. Rituximab - Wikipedia

   en.wikipedia.org/wiki/Rituximab

   Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...

5. List of long term side effects of antipsychotics - Wikipedia

   en.wikipedia.org/wiki/List_of_long_term_side...

   This article needs more reliable medical references for verification or relies too heavily on primary sources, specifically: Unsourced list of side effects, needs references. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed

6. Merck's Keytruda combo succeeds in late-stage trial for ... - AOL

   www.aol.com/news/mercks-keytruda-combo-succeeds...

   (Reuters) -Merck said on Friday its blockbuster immunotherapy Keytruda, in combination with chemoradiotherapy, met the main goal of improving overall survival for newly diagnosed patients with a ...

7. Merck's Keytruda combo gets FDA nod for expanded use in ... - AOL

   www.aol.com/news/mercks-keytruda-combo-gets-fda...

   Merck's top-selling drug Keytruda helps the body's own immune system fend off cancer by blocking a protein called PD-1. It has been approved to treat more than ten kinds of cancer.

8. PD-1 and PD-L1 inhibitors - Wikipedia

   en.wikipedia.org/wiki/PD-1_and_PD-L1_inhibitors

   Positive immunostaining can predict response to the treatment. PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitor anticancer drugs that block the activity of PD-1 and PDL1 immune checkpoint proteins present on the surface of cells. Immune checkpoint inhibitors are emerging as a front-line treatment for several types of ...

9. Merck's Keytruda Combination Gets EC Nod for Kidney Cancer - AOL

   www.aol.com/news/mercks-keytruda-combination...

   Merck's (MRK) label expansion application for Keytruda in combination with Pfizer's Inlyta for the first-line treatment of renal cell carcinoma gets approval in Europe.